Infectious disease has come to the forefront of medicine on the national stage and, in the midst of the COVID-19 pandemic, influenza season is upon us. How will UPMC managing flu testing and monitor circulating viruses? What are our strategies for health care workers going into the season? Looking beyond COVID-19, what is on the horizon with the often multi-drug resistant and difficult to identify Candida auris? What are UPMC’s surveillance and preparedness plans moving forward? Finally, surrounded by the opioid crisis that has driven an incredible burden of endocarditis in the region, how does the endocarditis service fit into our practice, and how can it help our patients? Join us for “What’s new in Infectious Diseases: COVID-19 and beyond” to find out!
Department of Medicine Grand Rounds
October 13, 2020
“What’s new in Infectious Diseases: COVID-19 and beyond“
1:54 COVID-19 Update
Ghady Haidar, MD, Assistant Professor of Medicine, Division of Infectious Diseases
Program Director of the Transplant Infectious Diseases Fellowship Program
15:10 Influenza during COVID-19
Graham Snyder, MD, Associate Professor of Medicine, Division of Infectious Diseases
Medical Director, Infection Prevention
24:32 What is Candida auris and why it is a big deal?
Neil Clancy, MD, Associate Professor of Medicine, Division of Infectious Diseases
Chief, Infectious Diseases Section, VA Pittsburgh Health Care System
36:55 Endocarditis Year in Review: The impact of multidisciplinary care teams
Sami El-Dalati, MD, Assistant Professor of Medicine, Division of Infectious Diseases
Director, Endovascular Infection Service
51:38 Closing Remarks
Mark Gladwin, MD, Jack D. Myers Distinguished Professor and Chair
Department of Medicine
View Presentation | CME Module
